BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30967472)

  • 1. The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors.
    Huang T; González YR; Qu D; Huang E; Safarpour F; Wang E; Joselin A; Im DS; Callaghan SM; Boonying W; Julian L; Dunwoodie SL; Slack RS; Park DS
    J Biol Chem; 2019 May; 294(21):8617-8629. PubMed ID: 30967472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ischemic neuronal death by E2F4-p130 protein complexes.
    Iyirhiaro GO; Zhang Y; Estey C; O'Hare MJ; Safarpour F; Parsanejad M; Wang S; Abdel-Messih E; Callaghan SM; During MJ; Slack RS; Park DS
    J Biol Chem; 2014 Jun; 289(26):18202-13. PubMed ID: 24828495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.
    Panchanathan R; Xin H; Choubey D
    J Immunol; 2008 May; 180(9):5927-34. PubMed ID: 18424712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment.
    Fry CJ; Pearson A; Malinowski E; Bartley SM; Greenblatt J; Farnham PJ
    J Biol Chem; 1999 May; 274(22):15883-91. PubMed ID: 10336493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.
    Dingar D; Konecny F; Zou J; Sun X; von Harsdorf R
    J Mol Cell Cardiol; 2012 Dec; 53(6):820-8. PubMed ID: 22985930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
    Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
    Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
    Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
    Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.
    Gonzalez YR; Zhang Y; Behzadpoor D; Cregan S; Bamforth S; Slack RS; Park DS
    J Neurosci; 2008 May; 28(21):5559-69. PubMed ID: 18495890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
    Croxton R; Ma Y; Cress WD
    Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the cyclin D3 promoter by E2F1.
    Ma Y; Yuan J; Huang M; Jove R; Cress WD
    J Biol Chem; 2003 May; 278(19):16770-6. PubMed ID: 12611887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.
    Xu X; Bieda M; Jin VX; Rabinovich A; Oberley MJ; Green R; Farnham PJ
    Genome Res; 2007 Nov; 17(11):1550-61. PubMed ID: 17908821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo.
    Jiang SX; Sheldrick M; Desbois A; Slinn J; Hou ST
    Mol Cell Biol; 2007 Mar; 27(5):1696-705. PubMed ID: 17178835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.
    Aubrecht TG; Faden AI; Sabirzhanov B; Glaser EP; Roelofs BA; Polster BM; Makarevich O; Stoica BA
    Cell Death Dis; 2018 Nov; 9(11):1121. PubMed ID: 30401820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.